Spinal fusion using bone morphogenetic proteins.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 15315040.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Dr. Harvinder Sandhu, one of the lead investigators in clinical trials that resulted in the approval of bone morphogenetic protein-2 (BMP) for spinal fusion, updates Orthopedics on the current status of BMPs.
Medical subject headings
- Bone Morphogenetic Proteins
- Spinal Fusion